UPLOAD Filing
Allarity Therapeutics, Inc.
Date: Sept. 29, 2025 · CIK: 0001860657 · Accession: 0000000000-25-010628
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290521
Letter
Re: Allarity Therapeutics, Inc. Registration Statement on Form S-3 Filed September 25, 2025 File No. 333-290521 Dear Thomas H. Jensen:
September 29, 2025
Thomas H. Jensen Chief Executive Officer Allarity Therapeutics, Inc. 123 E Tarpon Ave Tarpon Springs, FL 34689
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: William N. Haddad
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 29, 2025 Thomas H. Jensen Chief Executive Officer Allarity Therapeutics, Inc. 123 E Tarpon Ave Tarpon Springs, FL 34689 Re: Allarity Therapeutics, Inc. Registration Statement on Form S-3 Filed September 25, 2025 File No. 333-290521 Dear Thomas H. Jensen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: William N. Haddad </TEXT> </DOCUMENT>